Dr. Michael C. Raisch, MD

Dr. Raisch practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Raisch's NPI, 1023376928, was assigned on April 27, 2012. Dr. Raisch graduated from Duke University School Of Medicine in 2012. Dr. Raisch holds North Carolina license 182832.

Dr. Raisch's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Raisch's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Raisch to 1 more breast imaging center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raisch practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Raisch's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Raisch is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Raisch's licenses on file in 3 states: North Carolina, Colorado and Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Raisch treats.

CMS data shows 656 Medicare services from Dr. Raisch across 17 procedure codes in 2024, for 139 Medicare patients. Medicare paid $85,606 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Raisch in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raisch's median patient age at 76, with 39% women.

In 2024, Dr. Raisch wrote 52 Medicare Part D claims for 30 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $421 in total drug cost. In 2022, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Raisch for performance year 2024, reported through an alternative payment model (APM). Dr. Raisch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of melanoma (skin cancer) excision by Dr. Raisch, more than 79% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Raisch, published from 2006 to 2015. 2006 was the busiest year, with 2. The most frequent topics are Gene Expression Regulation, Developmental, Genome and Sea Urchins. Dr. Raisch has published most often in Dev Biol. Dr. Raisch's most frequent co-authors are Robert D. Burke, MD, Heather P. Lampel, MD and Robert Lefkowitz, MD.

CMS Open Payments shows 10 general payments to Dr. Raisch from 5 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Sun Pharmaceutical Industries Inc. paid the most, $62.

Dmand AI lists 1 award for Dr. Raisch, most recently Chief Resident in 2016.

Dr. Raisch graduated from Duke University School Of Medicine in 2012. Dr. Raisch is a member of AOA, AAD, AMA and ASDS.

Dr. Raisch is in network with 11 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.